We report the first known case of a breakthrough pulmonary infection caused by Aspergillus nomius in an acute myeloid leukemia patient receiving caspofungin therapy. The isolate was identified using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) and sequencing-based methods. The organism was found to be fully susceptible, in vitro, to echinocandin antifungal agents.
|Numero di pagine||5|
|Rivista||Medical mycology : official publication of the International Society for Human and Animal Mycology|
|Stato di pubblicazione||Pubblicato - 2012|